 | | | | NEW YORK (Reuters) - A U.S. jury on Monday ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable. | | |
| | | (Reuters) - Biohaven Pharmaceutical Holding said its treatment for acute migraine cleared two late-stage studies, but investors worried about its commercial viability as the efficacy data failed to distinguish from Allergan's rival treatment. | | |
| | | SEOUL (Reuters) - South Korea has confirmed a case of foot-and-mouth disease at a hog farm, the country's first discovery since February last year, its agriculture ministry said on Tuesday. | | |
| | | YORK, England (Reuters) - Nestle is launching a lower-sugar Milkybar made with a new version of the sweetener which could help ease the $185 billion confectionery industry's growing public health headache. | | |
| | | DUBLIN (Reuters) - Ireland's deputy premier has dropped his opposition to a government proposal allowing abortions up to 12 weeks into a pregnancy if a referendum to loosen legal curbs and hand parliament the power to legislate is passed in May. | | |
| | | (Reuters Health) - Smokers who say they want to kick the habit might have an easier time if they don’t use e-cigarettes, a U.S. study suggests. | | |
| | | SINGAPORE (Reuters) - Singapore's pharmaceuticals business, among the pillars of the city-state's manufacturing sector, is set to return to strength this year as big global drugmakers ramp up output and advance automation at their production sites across the country. | | |
| | | (Reuters Health) - Many patients with dangerously high cholesterol or a genetic predisposition to it don’t take statin drugs that can lower cholesterol, a U.S. study suggests. | | |
| | | ZURICH (Reuters) - Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks an edge on Merck and Bristol-Myers Squibb. | | |
| | | (Reuters Health) - Three in four food advertisements and half of drink promotions during major U.S. sports programs peddle high-calorie, sugary products, a new study suggests. | | |
|
| |
